FV 3 Analysis of cerebrospinal fluid (CSF) biomarkers to predict risk of clinical decline and progression to dementia in patients with mild cognitive impairment and mild cognitive symptoms. Issue 8 (August 2019) - Shaw, L.M.; Corradini, V.; Blennow, K.; Buck, K.; Eichenlaub, U.; Lifke, V.; Widmann, M.; Simon, M.; Hansson, O.